Huang, Yinan
Agarwal, Sandeep K.
Chatterjee, Satabdi
Chen, Hua
Johnson, Michael L.
Aparasu, Rajender R. https://orcid.org/0000-0003-2310-901X
Article History
Received: 26 April 2023
Revised: 22 June 2023
Accepted: 16 July 2023
First Online: 4 August 2023
Declarations
:
: The University of Houston’s Institutional Review Board approved the study protocol under the exempt category. Informed consent is not required as the MarketScan claims are based on de-identified medical information.
: This research did not receive any grant from funding agencies in the public, commercial, or not-for-profit sectors. Dr. Rajender R. Aparasu reports grants from Astellas, Incyte, and Novartis, outside the submitted work. The other authors have no personal or financial conflicts of interest to report.